APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Model for Testing

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

In our report, all the animals used in scientific purposes are included.

Selected research

Market Analysis & Forecast

Global Animal Model for Testing Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchAnimal Model for Testing Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Model for Testing Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Animal Model for Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Model for Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Model for Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

In our report, all the animals used in scientific purposes are included.

Read the full market overview

Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent.

In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.

Report Includes

This report presents an overview of global market for Animal Model for Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Model for Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Model for Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Model for Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Model for Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Model for Testing revenue, projected growth trends, production technology, application and end-user industry.

Animal Model for Testing Segment by Company

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Crown Biosciences

Shanghai SLAC

Shangghai Modelorg

GenOway

Syngene International

Psychogenics

Pharmaron

Pharmalegacy

Vitalstar Biotechnology

Animal Model for Testing Segment by Type

Rats

Mice

Others

Animal Model for Testing Segment by Application

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Animal Model for Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Model for Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Model for Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Model for Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Model for Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rats Major Player Table 3. Mice Major Player Table 4. Others Major Player Table 5. Global Animal Model for Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic and Research Institutes Major Player Table 7. Pharmaceutical and Biotechnology Companies Major Player Table 8. Animal Model for Testing Industry Trends Table 9. Animal Model for Testing Industry Drivers Table 10. Animal Model for Testing Industry Opportunities and Challenges Table 11. Animal Model for Testing Industry Restraints Table 12. Global Animal Model for Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Animal Model for Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Animal Model for Testing Market Share by Region (2021-2026) Table 15. Global Animal Model for Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Animal Model for Testing Market Share by Region (2027-2032) Table 17. Global Animal Model for Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Animal Model for Testing Revenue Market Share by Players (2021-2026) Table 19. Global Animal Model for Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Animal Model for Testing Key Players Headquarters & Area Served Table 21. Global Animal Model for Testing Players, Product Type & Application Table 22. Global Animal Model for Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Animal Model for Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Animal Model for Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Animal Model for Testing Revenue Market Share by Type (2021-2026) Table 29. Global Animal Model for Testing Revenue Market Share by Type (2027-2032) Table 30. Global Animal Model for Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Animal Model for Testing Revenue Market Share by Application (2021-2026) Table 34. Global Animal Model for Testing Revenue Market Share by Application (2027-2032) Table 35. Charles River Laboratories Company Information Table 36. Charles River Laboratories Business Overview Table 37. Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Charles River Laboratories Animal Model for Testing Product Portfolio Table 39. Charles River Laboratories Recent Development Table 40. Envigo Company Information Table 41. Envigo Business Overview Table 42. Envigo Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Envigo Animal Model for Testing Product Portfolio Table 44. Envigo Recent Development Table 45. Taconic Biosciences Company Information Table 46. Taconic Biosciences Business Overview Table 47. Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Taconic Biosciences Animal Model for Testing Product Portfolio Table 49. Taconic Biosciences Recent Development Table 50. Jackson Laboratory Company Information Table 51. Jackson Laboratory Business Overview Table 52. Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Jackson Laboratory Animal Model for Testing Product Portfolio Table 54. Jackson Laboratory Recent Development Table 55. Crown Biosciences Company Information Table 56. Crown Biosciences Business Overview Table 57. Crown Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Crown Biosciences Animal Model for Testing Product Portfolio Table 59. Crown Biosciences Recent Development Table 60. Shanghai SLAC Company Information Table 61. Shanghai SLAC Business Overview Table 62. Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shanghai SLAC Animal Model for Testing Product Portfolio Table 64. Shanghai SLAC Recent Development Table 65. Shangghai Modelorg Company Information Table 66. Shangghai Modelorg Business Overview Table 67. Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Shangghai Modelorg Animal Model for Testing Product Portfolio Table 69. Shangghai Modelorg Recent Development Table 70. GenOway Company Information Table 71. GenOway Business Overview Table 72. GenOway Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GenOway Animal Model for Testing Product Portfolio Table 74. GenOway Recent Development Table 75. Syngene International Company Information Table 76. Syngene International Business Overview Table 77. Syngene International Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Syngene International Animal Model for Testing Product Portfolio Table 79. Syngene International Recent Development Table 80. Psychogenics Company Information Table 81. Psychogenics Business Overview Table 82. Psychogenics Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Psychogenics Animal Model for Testing Product Portfolio Table 84. Psychogenics Recent Development Table 85. Pharmaron Company Information Table 86. Pharmaron Business Overview Table 87. Pharmaron Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pharmaron Animal Model for Testing Product Portfolio Table 89. Pharmaron Recent Development Table 90. Pharmalegacy Company Information Table 91. Pharmalegacy Business Overview Table 92. Pharmalegacy Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pharmalegacy Animal Model for Testing Product Portfolio Table 94. Pharmalegacy Recent Development Table 95. Vitalstar Biotechnology Company Information Table 96. Vitalstar Biotechnology Business Overview Table 97. Vitalstar Biotechnology Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Vitalstar Biotechnology Animal Model for Testing Product Portfolio Table 99. Vitalstar Biotechnology Recent Development Table 100. North America Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Animal Model for Testing Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Animal Model for Testing Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Animal Model for Testing Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Animal Model for Testing Revenue by Country (US$ Million) & (2027-2032) Table 114. China Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 115. China Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 116. China Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 117. China Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Animal Model for Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Animal Model for Testing Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Animal Model for Testing Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Animal Model for Testing Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Animal Model for Testing Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Animal Model for Testing Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Animal Model for Testing Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Animal Model for Testing Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Animal Model for Testing Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Animal Model for Testing Image Figure 2. Global Animal Model for Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Model for Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rats Image Figure 5. Mice Image Figure 6. Others Image Figure 7. Global Animal Model for Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Animal Model for Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic and Research Institutes Image Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. Global Animal Model for Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Animal Model for Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Animal Model for Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Animal Model for Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Animal Model for Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Animal Model for Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Animal Model for Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Animal Model for Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Animal Model for Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Animal Model for Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Animal Model for Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Animal Model for Testing Revenue Share by Type (2021-2032) Figure 24. North America Animal Model for Testing Revenue Share by Application (2021-2032) Figure 25. North America Animal Model for Testing Revenue Share by Country (2021-2032) Figure 26. United States Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Animal Model for Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Animal Model for Testing Revenue Share by Type (2021-2032) Figure 31. Europe Animal Model for Testing Revenue Share by Application (2021-2032) Figure 32. Europe Animal Model for Testing Revenue Share by Country (2021-2032) Figure 33. Germany Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Animal Model for Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Animal Model for Testing Revenue Share by Type (2021-2032) Figure 43. China Animal Model for Testing Revenue Share by Application (2021-2032) Figure 44. Asia Animal Model for Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Animal Model for Testing Revenue Share by Type (2021-2032) Figure 46. Asia Animal Model for Testing Revenue Share by Application (2021-2032) Figure 47. Asia Animal Model for Testing Revenue Share by Region (2021-2032) Figure 48. Japan Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Animal Model for Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Animal Model for Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Animal Model for Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Animal Model for Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Animal Model for Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Rats
  • Mice
  • Others
Applications
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • Charles River Laboratories
  • Envigo
  • Taconic Biosciences
  • Jackson Laboratory
  • Crown Biosciences
  • Shanghai SLAC
  • Shangghai Modelorg
  • GenOway
  • Syngene International
  • Psychogenics
  • Pharmaron
  • Pharmalegacy
  • Vitalstar Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Model for Testing Market by Type
  3. 1.2.1 Global Animal Model for Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rats
  5. 1.2.3 Mice
  6. 1.2.4 Others
  7. 1.3 Animal Model for Testing Market by Application
  8. 1.3.1 Global Animal Model for Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic and Research Institutes
  10. 1.3.3 Pharmaceutical and Biotechnology Companies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Animal Model for Testing Market Dynamics
  1. 2.1 Animal Model for Testing Industry Trends
  2. 2.2 Animal Model for Testing Industry Drivers
  3. 2.3 Animal Model for Testing Industry Opportunities and Challenges
  4. 2.4 Animal Model for Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Model for Testing Market Perspective (2021-2032)
  2. 3.2 Global Animal Model for Testing Growth Trends by Region
  3. 3.2.1 Global Animal Model for Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Model for Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Model for Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Model for Testing Revenue by Players
  2. 4.1.1 Global Animal Model for Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Model for Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Model for Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Model for Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Model for Testing Key Players Headquarters & Area Served
  7. 4.4 Global Animal Model for Testing Players, Product Type & Application
  8. 4.5 Global Animal Model for Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Model for Testing Market CR5 and HHI
  11. 4.6.3 2025 Animal Model for Testing Tier 1, Tier 2, and Tier 3
5 Animal Model for Testing Market Size by Type
  1. 5.1 Global Animal Model for Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Model for Testing Revenue by Type (2021-2032)
  3. 5.3 Global Animal Model for Testing Revenue Market Share by Type (2021-2032)
6 Animal Model for Testing Market Size by Application
  1. 6.1 Global Animal Model for Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Model for Testing Revenue by Application (2021-2032)
  3. 6.3 Global Animal Model for Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River Laboratories
  2. 7.1.1 Charles River Laboratories Company Information
  3. 7.1.2 Charles River Laboratories Business Overview
  4. 7.1.3 Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
  6. 7.1.5 Charles River Laboratories Recent Developments
  7. 7.2 Envigo
  8. 7.2.1 Envigo Company Information
  9. 7.2.2 Envigo Business Overview
  10. 7.2.3 Envigo Animal Model for Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Envigo Animal Model for Testing Product Portfolio
  12. 7.2.5 Envigo Recent Developments
  13. 7.3 Taconic Biosciences
  14. 7.3.1 Taconic Biosciences Company Information
  15. 7.3.2 Taconic Biosciences Business Overview
  16. 7.3.3 Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
  18. 7.3.5 Taconic Biosciences Recent Developments
  19. 7.4 Jackson Laboratory
  20. 7.4.1 Jackson Laboratory Company Information
  21. 7.4.2 Jackson Laboratory Business Overview
  22. 7.4.3 Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
  24. 7.4.5 Jackson Laboratory Recent Developments
  25. 7.5 Crown Biosciences
  26. 7.5.1 Crown Biosciences Company Information
  27. 7.5.2 Crown Biosciences Business Overview
  28. 7.5.3 Crown Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
  30. 7.5.5 Crown Biosciences Recent Developments
  31. 7.6 Shanghai SLAC
  32. 7.6.1 Shanghai SLAC Company Information
  33. 7.6.2 Shanghai SLAC Business Overview
  34. 7.6.3 Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
  36. 7.6.5 Shanghai SLAC Recent Developments
  37. 7.7 Shangghai Modelorg
  38. 7.7.1 Shangghai Modelorg Company Information
  39. 7.7.2 Shangghai Modelorg Business Overview
  40. 7.7.3 Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
  42. 7.7.5 Shangghai Modelorg Recent Developments
  43. 7.8 GenOway
  44. 7.8.1 GenOway Company Information
  45. 7.8.2 GenOway Business Overview
  46. 7.8.3 GenOway Animal Model for Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GenOway Animal Model for Testing Product Portfolio
  48. 7.8.5 GenOway Recent Developments
  49. 7.9 Syngene International
  50. 7.9.1 Syngene International Company Information
  51. 7.9.2 Syngene International Business Overview
  52. 7.9.3 Syngene International Animal Model for Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Syngene International Animal Model for Testing Product Portfolio
  54. 7.9.5 Syngene International Recent Developments
  55. 7.10 Psychogenics
  56. 7.10.1 Psychogenics Company Information
  57. 7.10.2 Psychogenics Business Overview
  58. 7.10.3 Psychogenics Animal Model for Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Psychogenics Animal Model for Testing Product Portfolio
  60. 7.10.5 Psychogenics Recent Developments
  61. 7.11 Pharmaron
  62. 7.11.1 Pharmaron Company Information
  63. 7.11.2 Pharmaron Business Overview
  64. 7.11.3 Pharmaron Animal Model for Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pharmaron Animal Model for Testing Product Portfolio
  66. 7.11.5 Pharmaron Recent Developments
  67. 7.12 Pharmalegacy
  68. 7.12.1 Pharmalegacy Company Information
  69. 7.12.2 Pharmalegacy Business Overview
  70. 7.12.3 Pharmalegacy Animal Model for Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
  72. 7.12.5 Pharmalegacy Recent Developments
  73. 7.13 Vitalstar Biotechnology
  74. 7.13.1 Vitalstar Biotechnology Company Information
  75. 7.13.2 Vitalstar Biotechnology Business Overview
  76. 7.13.3 Vitalstar Biotechnology Animal Model for Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
  78. 7.13.5 Vitalstar Biotechnology Recent Developments
8 North America
  1. 8.1 North America Animal Model for Testing Revenue (2021-2032)
  2. 8.2 North America Animal Model for Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Model for Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Model for Testing Revenue by Type (2027-2032)
  5. 8.3 North America Animal Model for Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Model for Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Model for Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Model for Testing Revenue by Application (2027-2032)
  9. 8.5 North America Animal Model for Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Model for Testing Revenue by Country
  11. 8.6.1 North America Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Model for Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Model for Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Animal Model for Testing Revenue (2021-2032)
  2. 9.2 Europe Animal Model for Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Model for Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Model for Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Model for Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Model for Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Model for Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Model for Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Model for Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Model for Testing Revenue by Country
  11. 9.6.1 Europe Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Model for Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Model for Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Animal Model for Testing Revenue (2021-2032)
  2. 10.2 China Animal Model for Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Model for Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Model for Testing Revenue by Type (2027-2032)
  5. 10.3 China Animal Model for Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Model for Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Model for Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Model for Testing Revenue by Application (2027-2032)
  9. 10.5 China Animal Model for Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Model for Testing Revenue (2021-2032)
  2. 11.2 Asia Animal Model for Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Model for Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Model for Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Model for Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Model for Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Model for Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Model for Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Model for Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Model for Testing Revenue by Country
  11. 11.6.1 Asia Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Model for Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Model for Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Model for Testing Revenue (2021-2032)
  2. 12.2 SAMEA Animal Model for Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Model for Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Model for Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Model for Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Model for Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Model for Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Model for Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Model for Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Model for Testing Revenue by Country
  11. 12.6.1 SAMEA Animal Model for Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Model for Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Model for Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst